Companies: 10,795·Total market cap: $144.5T
Medtronic plc

Medtronic plc

MDTNYSEHealthcare● Active
$80.24
$-1.43(-1.75%)
Market Cap$103.0B
P/E Ratio—
52W High$106.33
52W Low$73.31
Overview

Medtronic plc (MDT) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

MDT · cash on hand · updated Apr 25, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$8.96B▲ +12.0% vs prior year
FY · as of Apr 25, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$2.22B
cashAndCashEquivalents
Short-Term Investments
$6.75B
shortTermInvestments
YoY Change vs Prior Year
+12.0%
vs prior fiscal year
Latest Quarter
$8.38B
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: April 25, 2025

Net cash vs debt

Cash & ST Investments$8.96BCash on Hand
Total Debt$28.52BTotal Debt
Net Cash / Net Debt−$19.55BNet Debt Position
Cash vs Debt Ratio
Cash 24%Debt 76%

Medtronic plc carries a net debt position of $19.55B. Total debt ($28.52B) exceeds cash on hand ($8.96B). Medtronic plc cash vs debt ratio: 24% cash / 76% debt.

Net Cash = Cash & ST Investments − Total Debt$8.96B − $28.52B = −$19.55B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
MDT annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Apr 25, 2025Latest$8.96B+12.0%
Apr 26, 2024$8.01B+0.6%
Apr 28, 2023$7.96B-24.7%
Apr 29, 2022$10.57B-2.3%
Apr 30, 2021$10.82B-1.2%
MDT cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Medtronic plc
Medtronic plcYOU
MDT
$8.96B8.7%
#4
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#5
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Medtronic plc (MDT) cash on hand as of April 25, 2025 is $8.96B, comprising $2.22B in cash and cash equivalents (CCE) plus $6.75B in short-term investments — reported as Medtronic plc cash and short-term investments on the balance sheet (10-K filing). Also referred to as Medtronic plc cash reserves or cash position.

Medtronic plc annual cash on hand history shows increased +12.0% in 2025: increased +12.0% in 2025. Medtronic plc cash reserves in 2025 reflect the company's capital allocation strategy.

Medtronic plc carries total debt of $28.52B against cash of $8.96B, resulting in a net debt position of -$19.55B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

MDT cash on hand · 5 questions

As of April 25, 2025, Medtronic plc (MDT) has $8.96B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $2.22B in cash and cash equivalents (CCE) plus $6.75B in short-term investments. Latest quarter (January 23, 2026): $8.38B. Data sourced from the annual 10-K filing via FMP.

MDT cash on handMDT cash reservesMDT cash 2025how much cash does MDT have

▸ Source: FMP /balance-sheet-statement · US GAAP · Medtronic plc · Medtronic plc SEC 10-K & 10-Q filings · US GAAP · Last updated: April 25, 2025